Mechano-niche in Lung Repair after Injury

损伤后肺修复中的机械利基

基本信息

  • 批准号:
    10636629
  • 负责人:
  • 金额:
    $ 59.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-15 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Normal structure and function of the lung is maintained in homeostasis and repaired/regenerated following diverse injuries by regionally defined stem/progenitor cells. Stem cells reside in unique tissue microenvironments, known as the stem cell “niche”, which constitutes stem cell progeny, other niche-support cells including mesenchymal cells (MCs), and the surrounding extracellular matrix (ECM). The stem cell niche provides instructive cues for stem cell self-renewal and differentiation. Fibrotic lungs undergo substantial changes in the tissue biomechanical properties, manifested by stiffening of the ECM. Cells residing in the stem cell niche sense and respond to alterations in the stiffness of the microenvironment, highlighting matrix stiffness as an important mechanical component of the stem cell niche. In preliminary studies, we have characterized the stiffness of alveolar type 2 epithelial stem cell (AT2) niche associated with Pdgfrα+ lung MCs. Alveolar organoid culture in newly developed, stiffness-tunable 3D hydrogels demonstrated that matrix stiffness constitutes an AT2 niche. We recently identified that α6-integrin is a mechanosensitive integrin subunit; stiff matrix-induced α6 expression, primarily an α6 isoform with a shorter cytoplasmic domain (α6S), mediates lung fibroblast invasion into the basement membrane. New preliminary data now show that in addition to α6 expression, matrix stiffness regulates alternative splicing of α6 pre-mRNA in Pdgfrα+ lung MCs, resulting in differential expression of a distinct α6 isoform with a longer cytoplasmic domain (α6L) under soft /homeostatic matrix conditions and a switch from α6L to α6S predominance under stiff/fibrotic matrix conditions. We found that α6L expression promotes lipogenic differentiation of lung MCs and confers the AT2- niche function, facilitating reinstatement of lung homeostasis. In contrast, α6S expression impairs the AT2- niche function and promotes fibrogenic/invasive differentiation of lung MCs, contributing to lung fibrosis. In this proposal, we hypothesize that matrix stiffness-dependent alternative splicing of α6-integrin regulates the repair of injured lungs by controlling alveolotrophic vs. fibrogenic differentiation of lung mesenchymal cells. Specific aims in the proposed study are: (1) determination of the mechanisms by which matrix stiffness regulates alternative splicing of α6-integrin; (2) determination of the mechanisms by which distinct α6-integrin cytoplasmic variants mediate alveolotrophic vs. fibrogenic differentiation of lung mesenchymal cells; and (3) testing the potential of targeting matrix stiffness-dependent alternative splicing of α6-integrin for the reversal of sustained pulmonary fibrosis in mice. Understanding the mechanisms by which lung epithelial stem cells interact with their niches in normal vs. pathological repair of the injured lung will provide novel therapeutic approaches to prevent, treat, and potentially reverse pulmonary fibrosis.
肺的正常结构和功能保持在稳态中,并修复/再生以下 区域定义的茎/祖细胞造成的损伤。干细胞驻留在独特的组织中 微环境,称为干细胞“利基”,构成干细胞后代 包括间充质细胞(MCS)和周围细胞外基质(ECM)在内的细胞。干细胞小众 为干细胞自我更新和分化提供了启发性的提示。纤维化肺发生 组织生物力学特性的变化,表现为ECM的僵硬。居住在茎中的细胞 细胞生态位感并响应微环境刚度的改变,突出了矩阵 刚度是干细胞生态位的重要机械组成部分。在初步研究中,我们有 表征了与PDGFRα+肺MCS相关的2型肺泡2型上皮干细胞(AT2)的刚度。 新开发的,刚度可触摸的3D水凝胶中的牙槽有机培养表明基质 刚度构成一个AT2利基。我们最近确定α6-紧密蛋白是一种机械敏感的整联蛋白 亚基;刚性基质诱导的α6表达,一级Aα6同工型,具有较短的细胞质结构域(α6S), 介导肺成纤维细胞侵袭地下膜。新的初步数据现在表明 除α6表达外,矩阵刚度调节pDGFRα+肺MC中α6前MRNA的替代剪接, 导致在软中具有较长细胞质结构域(α6L)的不同α6同工型的差异表达 /稳态基质条件,从刚/纤维化基质下从α6L到α6S优势的转换 状况。我们发现α6L表达促进了肺MC的脂肪生成分化,并承认AT2- 利基功能,支持恢复肺稳态。相反,α6S表达会损害AT2- 利基功能并促进肺MC的纤维化/侵入性分化,导致肺纤维化。在这个 提案,我们假设矩阵刚度依赖性替代剪接α6-整合素可以调节修复 通过控制肺间充质细胞的肺泡和纤维分化,通过控制肺部受伤的肺。具体的 拟议的研究中的目的是:(1)确定基质刚度调节的机制 α6-整合素的替代剪接; (2)确定不同α6-整合蛋白的机制 胞质变体介导肺间充质细胞的肺泡和纤维造成分化。 (3) 测试靶向基质刚度依赖性的替代剪接的潜力,以逆转 小鼠持续的肺纤维化。了解肺上皮干细胞的机制 在正常与肺部病理修复中与壁ni的相互作用将提供新颖的疗法 预防,治疗和潜在反向肺纤维化的方法。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis.
  • DOI:
    10.7150/thno.81993
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    12.4
  • 作者:
    Mei Q;Yang Z;Xiang Z;Zuo H;Zhou Z;Dong X;Zhang L;Song W;Wang Y;Hu Q;Zhou Y;Qu J
  • 通讯作者:
    Qu J
Cell Adhesion Molecules in Fibrotic Diseases.
  • DOI:
    10.3390/biomedicines11071995
  • 发表时间:
    2023-07-14
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Hu, Qianjiang;Saleem, Komal;Pandey, Jyotsana;Charania, Arzoo N. N.;Zhou, Yong;He, Chao
  • 通讯作者:
    He, Chao
Targeting Asporin in Lung Fibrosis: A New Approach to an Old Concept.
Extracellular Matrix Stiffness in Lung Health and Disease.
  • DOI:
    10.1002/cphy.c210032
  • 发表时间:
    2022-06-29
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Guo, Ting;He, Chao;Venado, Aida;Zhou, Yong
  • 通讯作者:
    Zhou, Yong
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
共 5 条
  • 1
前往

YONG ZHOU的其他基金

Mechano-niche in Lung Repair after Injury
损伤后肺修复中的机械利基
  • 批准号:
    10428545
    10428545
  • 财政年份:
    2021
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Mechano-niche in Lung Repair after Injury
损伤后肺修复中的机械利基
  • 批准号:
    10178490
    10178490
  • 财政年份:
    2021
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Targeting Matrix Stiffness in Lung Fibrosis Associated with Aging
针对与衰老相关的肺纤维化的基质硬度
  • 批准号:
    9767855
    9767855
  • 财政年份:
    2018
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Targeting Matrix Stiffness in Lung Fibrosis Associated with Aging
针对与衰老相关的肺纤维化的基质硬度
  • 批准号:
    10227669
    10227669
  • 财政年份:
    2018
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Regulation of Mechano-Induced TGFb1 Activation and Myofibroblast Differentiation
机械诱导的 TGFb1 激活和肌成纤维细胞分化的调节
  • 批准号:
    7900399
    7900399
  • 财政年份:
    2009
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Regulation of Mechano-Induced TGFb1 Activation and Myofibroblast Differentiation
机械诱导的 TGFb1 激活和肌成纤维细胞分化的调节
  • 批准号:
    7708650
    7708650
  • 财政年份:
    2009
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:

相似国自然基金

玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
  • 批准号:
    42307523
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
  • 批准号:
    62372469
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
  • 批准号:
    82373219
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
  • 批准号:
    32300701
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
  • 批准号:
    82302332
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechano-niche in Lung Repair after Injury
损伤后肺修复中的机械利基
  • 批准号:
    10428545
    10428545
  • 财政年份:
    2021
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Mechano-niche in Lung Repair after Injury
损伤后肺修复中的机械利基
  • 批准号:
    10178490
    10178490
  • 财政年份:
    2021
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Validation of a single-pass surgical trajectory to enable AAV2-hAADC infusion into brainstem and mid-brain in nonhuman primate
验证单次手术轨迹,使 AAV2-hAADC 能够输注到非人灵长类动物的脑干和中脑
  • 批准号:
    10040048
    10040048
  • 财政年份:
    2020
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Irreversible electroporation for combinatorial GBM treatment
用于 GBM 组合治疗的不可逆电穿孔
  • 批准号:
    10220883
    10220883
  • 财政年份:
    2017
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别:
Monitoring and control of human liver cancer ablation using real-time, 3D echo decorrelation imaging
使用实时 3D 回波去相关成像监测和控制人类肝癌消融
  • 批准号:
    10176156
    10176156
  • 财政年份:
    2012
  • 资助金额:
    $ 59.01万
    $ 59.01万
  • 项目类别: